{"id":"https://openalex.org/W4367304592","doi":"https://doi.org/10.1212/wnl.0000000000203541","title":"Use of Efgartigimod in Treatment of Myasthenia Gravis Relapse after Possible Recurrence of Invasive Thymoma: A Case Report. (P1-5.011)","display_name":"Use of Efgartigimod in Treatment of Myasthenia Gravis Relapse after Possible Recurrence of Invasive Thymoma: A Case Report. (P1-5.011)","publication_year":2023,"publication_date":"2023-04-25","ids":{"openalex":"https://openalex.org/W4367304592","doi":"https://doi.org/10.1212/wnl.0000000000203541"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000203541","doi":"https://doi.org/10.1212/wnl.0000000000203541","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000203541","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013903486","display_name":"Fatai Momodu Akemokwe","orcid":"https://orcid.org/0000-0001-8195-5674","observed_orcids":["https://orcid.org/0000-0001-8195-5674"]},"institutions":[{"id":"https://openalex.org/I4210164563","display_name":"Neurology, Inc","ror":"https://ror.org/05ne0gd95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210164563"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fatai Akemokwe","raw_affiliation_strings":["Neurology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology","institution_ids":["https://openalex.org/I4210164563"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109280389","display_name":"Elif Pinar Coskun","orcid":"https://orcid.org/0000-0002-8010-8403","observed_orcids":["https://orcid.org/0000-0002-8010-8403"]},"institutions":[{"id":"https://openalex.org/I4210164563","display_name":"Neurology, Inc","ror":"https://ror.org/05ne0gd95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210164563"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elif Coskun","raw_affiliation_strings":["Neurology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology","institution_ids":["https://openalex.org/I4210164563"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113246816","display_name":"Shari L. Meyerson","orcid":"https://orcid.org/0009-0004-9560-7485","observed_orcids":["https://orcid.org/0009-0004-9560-7485"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shari Meyerson","raw_affiliation_strings":["Cardiothoracic Surgery, University of Kentucky"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiothoracic Surgery, University of Kentucky","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022800964","display_name":"Ima M. Ebong","orcid":"https://orcid.org/0000-0002-2265-4318","observed_orcids":["https://orcid.org/0000-0002-2265-4318"]},"institutions":[{"id":"https://openalex.org/I4210164563","display_name":"Neurology, Inc","ror":"https://ror.org/05ne0gd95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210164563"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ima Ebong","raw_affiliation_strings":["Neurology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology","institution_ids":["https://openalex.org/I4210164563"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1706,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.45772777,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"100","issue":"17_supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11627","display_name":"Autoimmune Neurological Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/efgartigimod","display_name":"efgartigimod","score":0.824999988079071},{"id":"https://openalex.org/keywords/myasthenia-gravis","display_name":"myasthenia gravis","score":0.984000027179718},{"id":"https://openalex.org/keywords/thymoma-recurrence","display_name":"thymoma recurrence","score":0.7950000166893005},{"id":"https://openalex.org/keywords/thymectomy","display_name":"thymectomy","score":0.6259999871253967},{"id":"https://openalex.org/keywords/acetylcholine-receptor-antibodies","display_name":"acetylcholine receptor antibodies","score":0.8960000276565552},{"id":"https://openalex.org/keywords/mycophenolate","display_name":"mycophenolate","score":0.6570000052452087},{"id":"https://openalex.org/keywords/adjuvant-radiotherapy","display_name":"adjuvant radiotherapy","score":0.7009999752044678},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.5830000042915344},{"id":"https://openalex.org/keywords/thymoma-associated-myasthenia-gravis","display_name":"thymoma-associated myasthenia gravis","score":0.777999997138977}],"concepts":[{"id":"https://openalex.org/C2779159893","wikidata":"https://www.wikidata.org/wiki/Q1429863","display_name":"Thymoma","level":2,"score":0.9347012042999268},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8947433233261108},{"id":"https://openalex.org/C2779615886","wikidata":"https://www.wikidata.org/wiki/Q3090790","display_name":"Thymectomy","level":3,"score":0.8416923880577087},{"id":"https://openalex.org/C2778105408","wikidata":"https://www.wikidata.org/wiki/Q8285","display_name":"Myasthenia gravis","level":2,"score":0.815969705581665},{"id":"https://openalex.org/C2781194658","wikidata":"https://www.wikidata.org/wiki/Q622427","display_name":"Ptosis","level":2,"score":0.7237833142280579},{"id":"https://openalex.org/C2779901103","wikidata":"https://www.wikidata.org/wiki/Q419472","display_name":"Pyridostigmine","level":3,"score":0.6498520374298096},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.624032199382782},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.5039886832237244},{"id":"https://openalex.org/C2781448737","wikidata":"https://www.wikidata.org/wiki/Q3177745","display_name":"Edrophonium","level":3,"score":0.4673132598400116},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39124488830566406}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000203541","doi":"https://doi.org/10.1212/wnl.0000000000203541","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000203541","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393231498","https://openalex.org/W4390731271","https://openalex.org/W7168392339","https://openalex.org/W4414766337","https://openalex.org/W4389869742","https://openalex.org/W4410183935","https://openalex.org/W4408244585","https://openalex.org/W4410023207","https://openalex.org/W4409226539","https://openalex.org/W4313651300"],"abstract_inverted_index":{"Objective:":[0],"NA":[1,49],"Background:":[2],"Myasthenia":[3],"gravis":[4],"is":[5,17,28],"an":[6,91],"autoimmune":[7],"neuromuscular":[8],"junction":[9],"disorder":[10],"with":[11,14,45,61,106,108,258,264,300],"established":[12],"association":[13],"thymoma.":[15,132,205],"There":[16],"no":[18],"consensus":[19],"on":[20,223],"optimal":[21],"treatment":[22,41],"of":[23,42,65,87,110,173,203,280,297],"recurrent":[24,66,265,301],"thymoma":[25],"post-resection.":[26],"Efgartigimod":[27],"a":[29,62,104,122,235,238,274],"first-in-class":[30],"FcRn":[31],"antagonist":[32],"approved":[33],"by":[34,147],"the":[35,111,248,295],"FDA":[36],"in":[37,58,117,162,209,217,252,294,310,318],"December":[38],"2021":[39,164],"for":[40,76,153,159],"AChR-antibody-positive":[43],"adults":[44],"generalized":[46,262],"MG.":[47],"Design/Methods:":[48],"Results:":[50],"A":[51],"53-year-old":[52],"right-handed":[53],"man":[54],"presented":[55],"to":[56,166,277,327,333,339],"us":[57],"September":[59,163,253],"2020":[60],"10-month":[63],"history":[64],"diplopia,":[67],"ptosis,":[68],"dysarthria,":[69],"dysphagia,":[70],"and":[71,81,100,102,145,175,220,229,271],"bilateral":[72],"hand":[73],"weakness.":[74],"Workup":[75],"MG":[77,263,298],"revealed":[78,121],"blocking,":[79],"binding,":[80],"modulating":[82],"AChR":[83,184,259],"antibodies.":[84],"CT":[85,189],"scan":[86],"his":[88],"chest":[89,188],"demonstrated":[90],"invasive":[92,124],"anterior":[93],"mediastinal":[94],"mass.":[95],"He":[96,133,140,150,206],"started":[97,207],"pyridostigmine,":[98],"mycophenolate":[99,168,268],"prednisone,":[101],"underwent":[103],"sternotomy":[105],"thymectomy":[107,270],"sparing":[109],"directly":[112],"adjacent":[113],"right":[114],"phrenic":[115],"nerve":[116],"October":[118],"2020.":[119],"Histopathology":[120],"locally":[123],"Masaoka":[125],"stage":[126],"IIIA,":[127],"pT1bN0M0,":[128],"WHO":[129],"type":[130],"B2":[131],"received":[134],"adjuvant":[135],"radiotherapy":[136,272],"until":[137],"January":[138],"2021.":[139,149],"was":[141],"weaned":[142],"off":[143],"prednisone":[144],"pyridostigmine":[146],"May":[148],"remained":[151,201],"asymptomatic":[152,245],"about":[154],"18":[155],"months":[156],"post-thymectomy":[157],"except":[158],"transient":[160],"dysarthria":[161],"attributed":[165],"missed":[167],"doses.":[169],"Patient":[170],"noticed":[171],"recrudescence":[172],"bulbar":[174],"respiratory":[176],"symptoms":[177,232,266,302],"around":[178],"April":[179],"2022.":[180,254],"Tests":[181],"showed":[182,273],"elevated":[183],"antibodies":[185],"but":[186,241],"surveillance":[187],"scans":[190],"did":[191],"not":[192],"demonstrate":[193],"tumor":[194],"recurrence":[195],"or":[196],"metastases.":[197],"His":[198,231],"cardiothoracic":[199],"surgeon":[200],"suspicious":[202],"residual":[204],"efgartigimod":[208,250,281,290],"July":[210],"2022":[211],"which":[212],"he":[213,242],"tolerated":[214],"well,":[215],"resulting":[216],"symptom":[218],"resolution":[219],"objective":[221],"improvement":[222],"MG-specific":[224],"outcome":[225],"measures":[226],"(MG-ADL,":[227],"MG-QoL15r":[228],"MGC).":[230],"recurred":[233],"during":[234],"COVID-19":[236],"infection":[237],"month":[239],"later,":[240],"rapidly":[243],"became":[244],"after":[246,303],"completing":[247],"second":[249],"cycle":[251],"Conclusions:":[255],"Our":[256],"patient":[257],"antibody-positive,":[260],"thymoma-associated,":[261],"despite":[267],"treatment,":[269],"dramatic":[275],"response":[276],"initial":[278],"cycles":[279],"therapy":[282],"without":[283],"significant":[284],"adverse":[285],"effects.":[286],"We":[287],"propose":[288],"that":[289],"be":[291],"considered":[292],"early":[293],"management":[296],"patients":[299],"thymectomy.":[304],"Disclosure:":[305],"Dr.":[306,314,323,329,335],"Akemokwe":[307,315],"has":[308,316,325,331,337],"stock":[309,317],"CVS":[311],"HEALTH":[312],"CORP.":[313],"LABORATORY":[319],"CORP":[320],"AMERICAN":[321],"HOLDINGS.":[322],"Coskun":[324],"nothing":[326,332,338],"disclose.":[328,334,340],"Meyerson":[330],"Ebong":[336]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-04-29T00:00:00"}